​

Total Infinitely Adjustable Length Innovation From OSSIO

 

This Thanksgiving, we are celebrating major advancements in orthopedic surgery made by OSSIO, Inc. The company recently expanded its range of bio-integrative fixation implants with the introduction of the OSSIOfiber Threaded Trimmable Fixation Nail.

 

Cut to length, sharpen the tip

 

The implant features a customizable length and a unique ”pencil sharpener” for the tip, making it the first of its kind on the market. This innovation reduces the need for extensive inventory and offers more custom options to meet specific patient needs. 

 

Foot and ankle

 

The design team, led by hand surgeons, aimed to address the challenge of intramedullary (IM) metacarpal fracture fixation. Early cases for the foot and ankle include Lisfranc open reduction and internal fixation (ORIF) and toe fusions. However, the implant can be used in any situation where a traditional screw would typically be used. 

 

​

Thanksgiving Total Ankle Arthroplasty (TAA) Research Mash-up
by Vince Vacketta, DPM

 

The following is an overview of recent studies and findings related to TAA procedures.

 

Turkey (IN) BONEs: Yet another systematic review and more positive research surrounding the INBONE II TAA. The primary INBONE II shows a 96.5% survivorship at 44 months. In cases where revision TAA was performed using INBONE II, the survivorship rate was 93.9% at 25.9 months. Read more.

 

Mashed TATTRs: A multicenter study evaluated 36 total talus replacements and found a 94.5% survivorship rate at an average follow-up of 25 months. No difference was observed in outcomes between patients who received only total talus replacement (TTR) and those who underwent both TAA and TTR. Read more.

 

Trans-fibular perfection: A five-year outcome study conducted by design surgeon and senior author Lew Schon demonstrates a 100% survivorship rate for the Zimmer Trabecular Metal TAA. Additionally, there were no fibular non-unions. Read more.

 

TAA 10-year outcomes: Another systematic review of 595 patients who underwent TAA with 10-year follow-up shows variable survivorship rates ranging from 66% to 94.4%. The average time to failure spans from 4.6 to 13.8 years. The authors advocate standardizing survivorship definitions to enhance data interpretation. Read more.